Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2006 | 1 |
2021 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Quoted phrase not found in phrase index: "Leigh syndrome with leukodystrophy"
Page 1
Use of whole genome sequencing to determine genetic basis of suspected mitochondrial disorders: cohort study.
BMJ. 2021 Nov 3;375:e066288. doi: 10.1136/bmj-2021-066288.
BMJ. 2021.
PMID: 34732400
Free PMC article.
Clinical Trial.
OBJECTIVE: To determine whether whole genome sequencing can be used to define the molecular basis of suspected mitochondrial disease. DESIGN: Cohort study. SETTING: National Health Service, England, including secondary and tertiary care. ...Fourteen of the diagnoses (4% of …
OBJECTIVE: To determine whether whole genome sequencing can be used to define the molecular basis of suspected mitochondrial disease. …
Identification of diffuse and focal brain lesions by clinical magnetic resonance spectroscopy.
Kingsley PB, Shah TC, Woldenberg R.
Kingsley PB, et al.
NMR Biomed. 2006 Jun;19(4):435-62. doi: 10.1002/nbm.1039.
NMR Biomed. 2006.
PMID: 16763970
Review.
The purpose of this paper is to facilitate the comparison of magnetic resonance (MR) spectra acquired from unknown brain lesions with published spectra in order to help identify unknown lesions in clinical settings. The paper includes lists of references for published MR s …
The purpose of this paper is to facilitate the comparison of magnetic resonance (MR) spectra acquired from unknown brain lesions with publis …
Item in Clipboard
Cite
Cite